Skip to main content
CYPH
NASDAQ Life Sciences

Nasdaq Flags Cypherpunk Technologies for Sub-$1.00 Bid Price

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.739
Mkt Cap
$78.677M
52W Low
$0.232
52W High
$3.7
52W Position info
218% above low
Off High info
80% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

CYPH has more than doubled off its 52-week low of $0.232 on light trading volume (0.3× avg).

Summary

On July 20, 2026, Cypherpunk Technologies received a Nasdaq deficiency notice because its stock closed below $1.00 for 30 consecutive days. The company has until January 19, 2027, to regain compliance and may consider a reverse stock split.


Key Events · Legal and Risk Events · CYPH

  • Nasdaq Deficiency Notice Received

    On July 20, 2026, Nasdaq notified Cypherpunk Technologies that its closing bid price had been below the $1.00 minimum for 30 consecutive business days, violating Listing Rule 5550(a)(2).

  • Compliance Deadline Set

    The company has 180 days, until January 19, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. An additional 180-day extension may be available if certain conditions are met.

  • Reverse Stock Split Considered

    Management stated it will consider all options to regain compliance, including a reverse stock split, though no assurance of success was given.

  • Recent Financial Distress

    The deficiency notice follows a $77.2 million net loss in Q1 2026 and declining cash and digital asset balances, as reported in the May 2026 10-Q.


Analysis · CYPH · Life Sciences

Nasdaq has notified Cypherpunk Technologies that its stock price fell below the $1.00 minimum for 30 consecutive business days, putting the listing at risk. The company now has 180 days to regain compliance, with a possible 180-day extension. This notice arrives just two months after Cypherpunk regained compliance from a prior bid price deficiency, and against a backdrop of a $77.2 million net loss in Q1 2026 and declining cash reserves. While the notice does not immediately delist the stock, it signals ongoing financial distress and raises the specter of a reverse stock split to meet the requirement.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CYPH was trading at $0.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $78.7M. The 52-week trading range was $0.23 to $3.70. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CYPH - Latest Insights

CYPH
Nov 16, 2026, 1:43 PM EST
Source: The Block
Importance Score:
7
Price at Filing: $1.85
Real-time Price: $2.08 info
Change: +$0.225 (+12%) info
Market Cap: $223.611M info
CYPH
Nov 16, 2026, 7:00 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.78
Real-time Price: $2.08 info
Change: +$0.295 (+17%) info
Market Cap: $223.611M info
CYPH
Nov 16, 2026, 6:50 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.73
Real-time Price: $2.08 info
Change: +$0.345 (+20%) info
Market Cap: $223.611M info
CYPH
Aug 19, 2026, 6:55 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.07
Real-time Price: $2.08 info
Change: +$1.00 (+93%) info
Market Cap: $223.611M info
CYPH
Aug 19, 2026, 6:54 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.07
Real-time Price: $2.08 info
Change: +$1.00 (+93%) info
Market Cap: $223.611M info